Interagency Statement on Promoting Local Production of Medicines and other Health Technologies

Overview

Strengthening local production is a cross-cutting endeavour. Sustainable local production requires effective multisectoral collaboration in order to promote enabling investment, legal and technical environments. In many LMICs, the capacity of both local manufacturers to produce and supply quality medical products and the national regulatory authority to ensure quality, efficacy and safety is insufficient. Any supply of medical products – both through local production and imports – should go hand in hand with the strengthening of regulatory capacities in order to achieve compliance with international GxP and other quality standards. Close partnership between the international community and LMICs is essential to support countries and regions to build the capacities, institutions and industries that can sustain the progress made.

WHO Team
Local Production and Assistance (LPA)
Number of pages
-2